Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (924) 924
Publication (122) 122
Book / eBook (16) 16
Book Review (4) 4
Conference Proceeding (3) 3
Book Chapter (2) 2
Magazine Article (2) 2
Data Set (1) 1
Microfilm (1) 1
Patent (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiac & cardiovascular systems (412) 412
humans (356) 356
index medicus (351) 351
female (224) 224
male (223) 223
middle aged (178) 178
percutaneous coronary intervention (176) 176
aged (170) 170
treatment outcome (153) 153
stents (140) 140
drug-eluting stents (122) 122
cardiovascular (121) 121
heart attacks (104) 104
clopidogrel (100) 100
thrombosis (94) 94
abridged index medicus (91) 91
time factors (90) 90
implantation (88) 88
mortality (87) 87
myocardial infarction (86) 86
stent (84) 84
cardiology (82) 82
acute coronary syndromes (80) 80
intervention (76) 76
risk factors (76) 76
angioplasty (74) 74
analysis (70) 70
acute myocardial-infarction (69) 69
cardiology and cardiovascular medicine (67) 67
outcomes (67) 67
coronary heart disease (66) 66
myocardial-infarction (62) 62
aspirin (60) 60
care and treatment (59) 59
coronary angiography (59) 59
transluminal angioplasty (58) 58
drug-eluting stent (56) 56
coronary vessels (55) 55
follow-up studies (54) 54
percutaneous coronary intervention - adverse effects (54) 54
platelet aggregation inhibitors - administration & dosage (54) 54
cardiac patients (53) 53
prospective studies (53) 53
risk assessment (53) 53
cardiovascular disease (51) 51
platelet aggregation inhibitors - therapeutic use (51) 51
randomized controlled trials as topic (51) 51
dual antiplatelet therapy (50) 50
ticlopidine - analogs & derivatives (50) 50
patients (49) 49
revascularization (48) 48
bare-metal stents (47) 47
bleeding (47) 47
acute coronary syndrome (45) 45
coronary artery disease - therapy (45) 45
myocardial infarction - therapy (45) 45
risk (45) 45
clinical trials (43) 43
metaanalysis (43) 43
peripheral vascular disease (43) 43
trial (43) 43
coronary artery disease (42) 42
internal medicine (42) 42
sirolimus - administration & dosage (42) 42
aged, 80 and over (41) 41
angioplasty, balloon, coronary (41) 41
research (41) 41
medicine, general & internal (40) 40
stent thrombosis (40) 40
antioxidants (39) 39
guidelines (39) 39
heart attack (39) 39
percutaneous coronary intervention - methods (39) 39
therapy (39) 39
drug therapy, combination (38) 38
studies (38) 38
percutaneous coronary intervention - mortality (37) 37
drug therapy (36) 36
myocardial infarction - mortality (36) 36
patient outcomes (36) 36
stroke (36) 36
ticagrelor (36) 36
artery-disease (35) 35
coronary artery disease - mortality (35) 35
platelet aggregation inhibitors - adverse effects (35) 35
impact (33) 33
prasugrel (33) 33
registries (33) 33
stenosis (33) 33
clinical-outcomes (32) 32
elevation myocardial-infarction (32) 32
prognosis (32) 32
tirofiban (32) 32
abciximab (31) 31
adult (31) 31
follow-up (31) 31
myocardial infarction - etiology (31) 31
clinical outcomes (30) 30
percutaneous coronary intervention - instrumentation (30) 30
ticlopidine - administration & dosage (30) 30
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (868) 868
Italian (65) 65
French (6) 6
Polish (4) 4
German (3) 3
Spanish (3) 3
Arabic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Le Coefore [di] Eschilo
: Traduzione e commentario critico di M. Valgimigli
by Aeschylus and Valgimigli, Manara, 1876-1965
1948, 2. Ed., Biblioteca di cultura moderna, 221
Book
Details down arrow
2. Full Text Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial
by Valgimigli, Marco, Dr and Gagnor, Andrea, MD and Calabró, Paolo, MD and Frigoli, Enrico, MD and Leonardi, Sergio, MD and Zaro, Tiziana, MD and Rubartelli, Paolo, MD and Briguori, Carlo, MD and Andò, Giuseppe, MD and Repetto, Alessandra, MD and Limbruno, Ugo, MD and Cortese, Bernardo, MD and Sganzerla, Paolo, MD and Lupi, Alessandro, MD and Galli, Mario, MD and Colangelo, Salvatore, MD and Ierna, Salvatore, MD and Ausiello, Arturo, MD and Presbitero, Patrizia, MD and Sardella, Gennaro, Prof and Varbella, Ferdinando, MD and Esposito, Giovanni, MD and Santarelli, Andrea, MD and Tresoldi, Simone, MD and Nazzaro, Marco, MD and Zingarelli, Antonio, MD and de Cesare, Nicoletta, MD and Rigattieri, Stefano, MD and Tosi, Paolo, MD and Palmieri, Cataldo, MD and Brugaletta, Salvatore, MD and Rao, Sunil V, MD and Heg, Dik, PhD and Rothenbühler, Martina, MSc and Vranckx, Pascal, MD and Jüni, Peter, Prof and MATRIX Investigators
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9986, pp. 2465 - 2476
Summary Background It is unclear whether radial compared with femoral access improves outcomes in unselected patients with acute coronary syndromes undergoing... 
Internal Medicine | LEARNING-CURVE | SITE | MEDICINE, GENERAL & INTERNAL | ANGIOGRAPHY | METAANALYSIS | ACUTE MYOCARDIAL-INFARCTION | OUTCOMES | ST-SEGMENT ELEVATION | CARDIOVASCULAR DATA REGISTRY | INTERVENTION | ASSOCIATION | Catheterization, Peripheral - methods | Blood Loss, Surgical - prevention & control | Humans | Acute Coronary Syndrome - mortality | Male | Survival Rate | Treatment Outcome | Cause of Death | Coronary Angiography | Radial Artery | Percutaneous Coronary Intervention - methods | Acute Coronary Syndrome - surgery | Female | Femoral Artery | Aged | Blood Loss, Surgical - mortality | Catheterization, Peripheral - adverse effects | Clinical trials | Care and treatment | Coronary heart disease | Cardiac patients | Heart attacks | Acute coronary syndromes | Cardiology | Mortality | Veins & arteries
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Quaranta lettere a Manara (e a Erse) Valgimigli
: con quattro lettere di M. Valgimigli
by Marchesi, Concetto, 1878-1957 and Valgimigli, Manara, 1876-1965 and Valgimigli, Erse, 1909-1940 and De Luca, Iginio
1979, 73
Correspondence | Valgimigli, Erse, 1909-1940 | Valgimigli, Manara, 1876-1965 | Philologists
Book
Details down arrow
4. Full Text Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial
by Sabate, Manel, Dr and Cequier, Angel, MD and Iñiguez, Andrés, MD and Serra, Antonio, MD and Hernandez-Antolin, Rosana, MD and Mainar, Vicente, MD and Valgimigli, Marco, MD and Tespili, Maurizio, MD and den Heijer, Pieter, MD and Bethencourt, Armando, MD and Vazquez, Nicolás, MD and Gómez-Hospital, Joan Antoni, MD and Baz, José Antonio, MD and Martin-Yuste, Victoria, MD and van Geuns, Robert-Jan, MD and Alfonso, Fernando, MD and Bordes, Pascual, MD and Tebaldi, Matteo, MD and Masotti, Monica, MD and Silvestro, Antonio, MD and Backx, Bianca, PhD and Brugaletta, Salvatore, MD and van Es, Gerrit Anne, PhD and Serruys, Patrick W, Prof
Lancet, The, ISSN 0140-6736, 2012, Volume 380, Issue 9852, pp. 1482 - 1490
Summary Background Everolimus-eluting stent (EES) reduces the risk of restenosis in elective percutaneous coronary intervention. However, the use of... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | UNCOATED STENTS | MULTICENTER | DESIGN | REVASCULARIZATION | THROMBOSIS | IMPLANTATION | CORONARY STENT | FOLLOW-UP | GLYCOPROTEIN IIB/IIIA INHIBITOR | CLINICAL-PRACTICE | Single-Blind Method | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Humans | Middle Aged | Male | Chromium Alloys | Myocardial Infarction - therapy | Sirolimus - administration & dosage | Electrocardiography | Female | Myocardial Infarction - physiopathology | Everolimus | Stents | Immunosuppressive Agents - administration & dosage | Care and treatment | Usage | Patient outcomes | Research | Comparative analysis | Heart attack | Stent (Surgery) | Heart attacks | Drug therapy | Drug dosages
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI
by Giustino, Gennaro, MD and Chieffo, Alaide, MD and Palmerini, Tullio, MD and Valgimigli, Marco, MD, PhD and Feres, Fausto, MD and Abizaid, Alexandre, MD and Costa, Ricardo A., MD and Hong, Myeong-Ki, MD, PhD and Kim, Byeong-Keuk, MD, PhD and Jang, Yangsoo, MD, PhD and Kim, Hyo-Soo, MD, PhD and Park, Kyung Woo, MD and Gilard, Martine, MD and Morice, Marie-Claude, MD and Sawaya, Fadi, MD and Sardella, Gennaro, MD and Genereux, Philippe, MD and Redfors, Bjorn, MD, PhD and Leon, Martin B., MD and Bhatt, Deepak L., MD, MPH and Stone, Gregg W., MD and Colombo, Antonio, MD
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 68, Issue 17, pp. 1851 - 1864
Abstract Background Optimal upfront dual antiplatelet therapy (DAPT) duration after complex percutaneous coronary intervention (PCI) with drug-eluting stents... 
Cardiovascular | Internal Medicine | bleeding | drug-eluting stents | stent thrombosis | myocardial infarction | CARDIAC & CARDIOVASCULAR SYSTEMS | THROMBOSIS | LENGTH | RISK | OUTCOMES | ELUTING STENT IMPLANTATION | DURATION | Drug-Eluting Stents | Humans | Middle Aged | Postoperative Complications - prevention & control | Male | Treatment Outcome | Postoperative Complications - epidemiology | Ticlopidine - analogs & derivatives | Aspirin - administration & dosage | Randomized Controlled Trials as Topic | Time Factors | Aspirin - adverse effects | Percutaneous Coronary Intervention - methods | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Drug Therapy, Combination | Postoperative Complications - chemically induced | Platelet Aggregation Inhibitors - adverse effects | Transluminal angioplasty | Medical colleges | Continuing medical education | Cardiac patients | Medical care | Research institutes | Cardiology | Quality management | Studies | Short term | Heart attacks | Mortality | Clinical trials | Cardiovascular disease | Diabetes | Stents | Thrombosis | Patients | Data bases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Le Coefore [di] Eschilo
: Introd. e commento di M. Valgimigli e M.V. Ghezzo. Nota scenografica de C. Anti
by Aeschylus and Valgimigli, Manara, 1876-1965 and Ghezzo, Maria Vittoria
1962, 2. ed., riv., Classici latini e greci, commentati per le scuole, 152
Book
Details down arrow
7. Full Text Zotarolimus-Eluting Versus Bare-Metal Stents in Uncertain Drug-Eluting Stent Candidates
by Valgimigli, Marco, MD, PhD and Patialiakas, Athanasios, MD and Thury, Attila, MD, PhD and McFadden, Eugene, MD and Colangelo, Salvatore, MD and Campo, Gianluca, MD and Tebaldi, Matteo, MD and Ungi, Imre, MD, PhD and Tondi, Stefano, MD and Roffi, Marco, MD and Menozzi, Alberto, MD, PhD and de Cesare, Nicoletta, MD and Garbo, Roberto, MD and Meliga, Emanuele, MD and Testa, Luca, MD, PhD and Gabriel, Henrique Mesquita, MD and Airoldi, Flavio, MD and Ferlini, Marco, MD and Liistro, Francesco, MD and Dellavalle, Antonio, MD and Vranckx, Pascal, MD, PhD and Briguori, Carlo, MD, PhD and ZEUS Investigators
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 65, Issue 8, pp. 805 - 815
Abstract Background The use of drug-eluting stents (DES) in patients at high risk of bleeding or thrombosis has not been prospectively studied; limited data... 
Cardiovascular | Internal Medicine | dual-antiplatelet therapy | high bleeding risk | high thrombotic risk | zotarolimus-eluting stent(s) | drug-eluting stent(s) | dualantiplatelet therapy | DESIGN | CARDIAC & CARDIOVASCULAR SYSTEMS | NEOINTIMAL COVERAGE | ANGIOPLASTY | IMPLANTATION | POLYMER | ACUTE MYOCARDIAL-INFARCTION | OUTCOMES | DURATION | Coronary Artery Disease - surgery | Humans | Immunosuppressive Agents - therapeutic use | Postoperative Complications - prevention & control | Male | Hemorrhage - prevention & control | Aspirin - administration & dosage | Drug-Eluting Stents - adverse effects | Coronary Restenosis - diagnosis | Coronary Angiography - methods | Aspirin - adverse effects | Percutaneous Coronary Intervention - methods | Hemorrhage - etiology | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Aged, 80 and over | Ticlopidine - administration & dosage | Female | Coronary Restenosis - etiology | Platelet Aggregation Inhibitors - adverse effects | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Risk Assessment | Risk Factors | Coronary Restenosis - prevention & control | Treatment Outcome | Postoperative Complications - diagnosis | Ticlopidine - analogs & derivatives | Coronary Artery Disease - diagnosis | Aged | Biocompatible Materials - therapeutic use | Percutaneous Coronary Intervention - adverse effects | Sects | Stent (Surgery) | Heart attacks | Drug therapy | Stents | Coronary vessels
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: The AVIO trial
by Chieffo, Alaide, MD and Latib, Azeem, MD and Caussin, Christophe, MD and Presbitero, Patrizia, MD and Galli, Stefano, MD and Menozzi, Alberto, MD and Varbella, Ferdinando, MD and Mauri, Fina, MD and Valgimigli, Marco, MD and Arampatzis, Chourmouzios, MD and Sabate, Manuel, MD and Erglis, Andrejs, MD and Reimers, Bernhard, MD and Airoldi, Flavio, MD and Laine, Mika, MD and Palop, Ramon Lopez, MD and Mikhail, Ghada, MD and MacCarthy, Philip, MD and Romeo, Francesco, MD and Colombo, Antonio, MD, FACC and AVIO Investigators
American Heart Journal, ISSN 0002-8703, 2013, Volume 165, Issue 1, pp. 65 - 72
Background No randomized studies have thus far evaluated intravascular ultrasound (IVUS) guidance in the drug-eluting stent (DES) era. The aim was to evaluate... 
Cardiovascular | RESTENOSIS | DEPLOYMENT | CARDIAC & CARDIOVASCULAR SYSTEMS | GUIDANCE | Ultrasonography, Interventional - methods | Drug-Eluting Stents | Prospective Studies | Follow-Up Studies | Risk Assessment | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Coronary Artery Disease - mortality | Thrombosis | Blood Vessel Prosthesis Implantation - mortality | Coronary Artery Disease - diagnostic imaging | Myocardial Infarction | Blood Vessel Prosthesis Implantation - adverse effects | Coronary Angiography - methods | Blood Vessel Prosthesis Implantation - methods | Survival Analysis | Female | Angiography | Comparative analysis | Stent (Surgery) | Heart attacks | Medical imaging | Laboratories | Stents | Mortality
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting
by Palmerini, Tullio, MD and Bacchi Reggiani, Letizia, MStat and Della Riva, Diego, MD and Romanello, Mattia, MD and Feres, Fausto, MD and Abizaid, Alexandre, MD and Gilard, Martine, MD and Morice, Marie-Claude, MD and Valgimigli, Marco, MD, PhD and Hong, Myeong-Ki, MD, PhD and Kim, Byeong-Keuk, MD, PhD and Jang, Yangsoo, MD, PhD and Kim, Hyo-Soo, MD, PhD and Park, Kyung Woo, MD and Colombo, Antonio, MD and Chieffo, Alaide, MD and Ahn, Jung-Min, MD and Park, Seung-Jung, MD and Schüpke, Stefanie, MD and Kastrati, Adnan, MD and Montalescot, Gilles, MD and Steg, Philippe Gabriel, MD and Diallo, Abdourahmane, MD and Vicaut, Eric, MD and Helft, Gerard, MD and Biondi-Zoccai, Giuseppe, MD, MStat and Xu, Bo, MD and Han, Yaling, MD and Genereux, Philippe, MD and Bhatt, Deepak L., MD, MPH and Stone, Gregg W., MD
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 16, pp. 2011 - 2022
Abstract Background Although some randomized controlled trials (RCTs) and meta-analyses have suggested that prolonged dual-antiplatelet therapy (DAPT) may be... 
Cardiovascular | Internal Medicine | mortality | drug-eluting stent | dual antiplatelet therapy | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | EVENTS | MYOCARDIAL-INFARCTION | EFFICACY | LONG-TERM MORTALITY | PAIRWISE | dual antiplatelet therapy | TRIAL | ELUTING STENTS | IMPLANTATION | ASSOCIATION | Drug-Eluting Stents | Humans | Platelet Aggregation Inhibitors - administration & dosage | Hemorrhage - mortality | Hemorrhage - chemically induced | Postoperative Complications - mortality | Postoperative Complications - chemically induced | Percutaneous Coronary Intervention | Platelet Aggregation Inhibitors - adverse effects | Randomized Controlled Trials as Topic | Medical colleges | Analysis | Mortality | Research institutes | Cardiology | Heart diseases | Stent (Surgery) | Therapy | Surgical implants | Heart attacks | Meetings | Clinical trials | Implantation | Drug delivery | Multivariate analysis | Patients | Bleeding | Meta-analysis | Confidence intervals | Studies | Motivation | Collaboration | Implants | Health hazards | Fatalities | Secondary analysis | Acute coronary syndromes | Stents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials
by Stefanini, Giulio G, MD and Baber, Usman, MD and Windecker, Stephan, Prof and Morice, Marie-Claude, MD and Sartori, Samantha, PhD and Leon, Martin B, Prof and Stone, Gregg W, Prof and Serruys, Patrick W, Prof and Wijns, William, MD and Weisz, Giora, MD and Camenzind, Edoardo, MD and Steg, Philippe G, Prof and Smits, Pieter C, MD and Kandzari, David, MD and Von Birgelen, Clemens, MD and Galatius, Søren, MD and Jeger, Raban V, MD and Kimura, Takeshi, Prof and Mikhail, Ghada W, MD and Itchhaporia, Dipti, MD and Mehta, Laxmi, MD and Ortega, Rebecca, MHA and Kim, Hyo-Soo, MD and Valgimigli, Marco, MD and Kastrati, Adnan, Prof and Chieffo, Alaide, MD and Mehran, Roxana, Dr Prof
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9908, pp. 1879 - 1888
Summary Background The safety and efficacy of drug-eluting stents (DES) in the treatment of coronary artery disease have been assessed in several randomised... 
Internal Medicine | METIS-302438 | IR-89428 | SLOW-RELEASE | MEDICINE, GENERAL & INTERNAL | BIODEGRADABLE POLYMER | BARE-METAL STENTS | LONG-TERM OUTCOMES | NON-INFERIORITY TRIAL | DOUBLE-BLIND | FOLLOW-UP | DURABLE POLYMER | CORONARY-ARTERY-DISEASE | NETWORK METAANALYSIS | Myocardial Infarction - mortality | Humans | Treatment Outcome | Coronary Artery Disease - mortality | Coronary Restenosis - therapy | Drug-Eluting Stents - adverse effects | Randomized Controlled Trials as Topic | Coronary Restenosis - epidemiology | Percutaneous Coronary Intervention - instrumentation | Coronary Artery Disease - therapy | Percutaneous Coronary Intervention - methods | Thrombosis - etiology | Sex Factors | Female | Thrombosis - mortality | Myocardial Infarction - etiology | Women | Care and treatment | Coronary heart disease | Health aspects | Drug-eluting stents | Studies | Heart attacks | Coronary vessels | Cardiovascular disease | Random variables | Gender | Acute coronary syndromes | Stents | Thrombosis | Patients
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial
by Lincoff, A Michael, Prof and Mehran, Roxana, Prof and Povsic, Thomas J, MD and Zelenkofske, Steven L, DO and Huang, Zhen, MS and Armstrong, Paul W, Prof and Steg, P Gabriel, Prof and Bode, Christoph, Prof and Cohen, Mauricio G, MD and Buller, Christopher, Prof and Laanmets, Peep, MD and Valgimigli, Marco, MD and Marandi, Toomas, MD and Fridrich, Viliam, MD and Cantor, Warren J, MD and Merkely, Bela, Prof and Lopez-Sendon, Jose, Prof and Cornel, Jan H, MD and Kasprzak, Jaroslaw D, Prof and Aschermann, Michael, Prof and Guetta, Victor, Prof and Morais, Joao, MD and Sinnaeve, Peter R, Prof and Huber, Kurt, Prof and Stables, Rod, DM and Sellers, Mary Ann, MSN and Borgman, Marilyn, BSN and Glenn, Lauren, MS and Levinson, Arnold I, Prof and Lopes, Renato D, MD and Hasselblad, Vic, Prof and Becker, Richard C, Prof and Alexander, John H, Prof and REGULATE-PCI Investigators
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10016, pp. 349 - 356
Summary Background REG1 is a novel anticoagulation system consisting of pegnivacogin, an RNA aptamer inhibitor of coagulation factor IXa, and anivamersen, a... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | REVASCULARIZATION | METAANALYSIS | EFFICACY | SAFETY | THROMBOSIS | RNA APTAMERS | ANTIBODY | COAGULATION | PHARMACODYNAMICS | INHIBITORS | Recombinant Proteins - therapeutic use | Hemorrhage - epidemiology | Hirudins | Humans | Middle Aged | Europe - epidemiology | Anticoagulants - therapeutic use | Aptamers, Nucleotide - therapeutic use | Male | Early Termination of Clinical Trials | Drug Hypersensitivity - epidemiology | Factor IXa - antagonists & inhibitors | Coagulants - administration & dosage | Female | Aged | Peptide Fragments - therapeutic use | North America - epidemiology | Oligonucleotides - administration & dosage | Percutaneous Coronary Intervention | Transluminal angioplasty | Clinical trials | Medical colleges | Anticoagulants (Medicine) | Hospitals | RNA | Anticoagulants | Stroke | Heart attacks | Heart surgery | Angioplasty | Mortality | Cardiovascular disease | Thrombosis | Clinical outcomes | Coronary vessels | Biomarkers | Patient safety | Cardiology | Acute coronary syndromes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease
by Stone, Gregg W and Sabik, Joseph F and Serruys, Patrick W and Simonton, Charles A and Généreux, Philippe and Puskas, John and Kandzari, David E and Morice, Marie-Claude and Lembo, Nicholas and Brown, W. Morris and Taggart, David P and Banning, Adrian and Merkely, Béla and Horkay, Ferenc and Boonstra, Piet W and van Boven, Ad J and Ungi, Imre and Bogáts, Gabor and Mansour, Samer and Noiseux, Nicolas and Sabaté, Manel and Pomar, José and Hickey, Mark and Gershlick, Anthony and Buszman, Pawel and Bochenek, Andrzej and Schampaert, Erick and Pagé, Pierre and Dressler, Ovidiu and Kosmidou, Ioanna and Mehran, Roxana and Pocock, Stuart J and Kappetein, A. Pieter and EXCEL Trial Investigators
The New England Journal of Medicine, ISSN 0028-4793, 12/2016, Volume 375, Issue 23, pp. 2223 - 2235
In a randomized trial, over 1900 patients with left main coronary artery disease were assigned to percutaneous coronary intervention or coronary-artery bypass... 
MEDICINE, GENERAL & INTERNAL | 5-YEAR OUTCOMES | CLINICAL IMPACT | SYNERGY | TAXUS | RANDOMIZED-TRIAL | FOLLOW-UP | INTERVENTION | INTRAVASCULAR ULTRASOUND GUIDANCE | SYNTAX | GRAFT-SURGERY | Care and treatment | Usage | Coronary artery bypass | Coronary arteries | Myocardial infarction | Cerebral infarction | Heart surgery | Coronary artery | Clinical trials | Cardiovascular disease | Drug delivery | Cobalt | Studies | Ischemia | Coronary vessels | Surgery | Implants | Chromium | Death | Heart diseases | Stents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights